Abstract: A single-dose oral formulation of spinosad and lufenuron and methods for its use in the extended control of a flea infestation on a domestic animal such as a dog without emesis.
Type:
Grant
Filed:
August 4, 2020
Date of Patent:
July 5, 2022
Assignee:
Piedmont Animal Health Inc.
Inventors:
Douglas Hepler, Roland Johnson, Gail Dempsey, Michael Kelly
Abstract: Provided herein are long-acting, non-aqueous pharmaceutically acceptable compositions of active ingredients for subcutaneous injection, in particular analgesics such as buprenorphine.
Type:
Grant
Filed:
January 31, 2020
Date of Patent:
July 13, 2021
Assignee:
Piedmont Animal Health Inc.
Inventors:
Douglas I. Hepler, Gail L. Dempsey, Dorothea Erxleben
Abstract: A single-dose oral formulation of spinosad and lufenuron and methods for its use in the extended control of a flea infestation on a domestic animal such as a dog without emesis.
Type:
Grant
Filed:
March 28, 2018
Date of Patent:
August 11, 2020
Assignee:
Piedmont Animal Health Inc.
Inventors:
Douglas Hepler, Roland Johnson, Gail Dempsey, Michael Kelly
Abstract: Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin. In particular, compositions containing azithromycin with low toxicity, especially for administration to felines, are provided herein.
Type:
Grant
Filed:
March 20, 2019
Date of Patent:
August 4, 2020
Assignee:
Piedmont Animal Health Inc.
Inventors:
Neil E. Paulsen, Gail L. Dempsey, Michael S. Daniel, Tiffany G. Tomlinson, Douglas Hepler, Raymond Petzold